Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells

DRUG2 trials

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Conditions

Acute Lymphoblastic LeukemiaAcute Lymphocytic LeukemiaB-cell LymphomaChronic Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaNon Hodgkin's Lymphoma

Phase 1

Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAcute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphoblastic Leukemia

Start: 2021-03-10End: 2024-03-10Target: 27Updated: 2021-03-15

Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAcute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma

Start: 2021-04-10End: 2024-03-10Target: 27Updated: 2021-04-08